Diet and atopic dermatitis

Cutis

Volumn 97, Issue 3, 2016, Pages 227-232

  Silverberg, Nanette B ^a,b   Lee Wong, Mary ^a,c   Yosipovitch, Gil ^b,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Dermatology ^*  (United States)

^c Department of Otolaryngology and Communicative Sciences   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLICATION; DERMATITIS, ATOPIC; DERMATOLOGY; DIET THERAPY; FOOD ALLERGY; HUMAN;

DERMATITIS, ATOPIC; DERMATOLOGY; FOOD HYPERSENSITIVITY; HUMANS;

EID: 85011311006     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Schachner L, Ling NS, Press S. A statistical analysis of a pediatric dermatology clinic. Pediatr Dermatol. 1983;1:157-164.
2. Kiprono SK, Muchunu JW, Masenga JE. Skin diseases in pediatric patients attending a tertiary dermatology hospital in Northern Tanzania: a cross-sectional study. BMC Dermatol. 2015;15:16.
3. Wensink M, Timmer C, Brand PL. Atopic dermatitis in infants not caused by food allergy [in Dutch]. Ned Tijdschr Geneeskd. 2008;152:4-9.
4. De Benedetto A, Kubo A, Beck LA. Skin barrier disruption: a requirement for allergen sensitizationJ Invest Dermatol. 2012;132(3, pt 2):949-963.
5. Margolis DJ, Apter AJ, Gupta J, et al. The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort. J Allergy Clin Immunol. 2012;130:912-917.
6. Hanifin JM. Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. J Invest Dermatol. 2009;129:320-322.
7. Batista DI, Perez L, Orfali RL, et al. Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1/Th2/Th17 cytokines in adults with atopic dermatitis. J Eur Acad Dermatol Venereol. 2015;29:1091-1095.
8. Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol. 1998;28:769-779.
9. Correa da Rosa J, Malajian D, Shemer A, et al. Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin. J Allergy Clin Immunol. 2015; 135:712-720.
10. Paller AS. Latest approaches to treating atopic dermatitis. Chem Immunol Allergy. 2012;96:132-140.
11. Cianferoni A, Spergel J. Eosinophilic esophagitis: a comprehensive review [published online July 22, 2015]. Clin Rev Allergy Immunol. doi:10. 1111/all. 12846.
12. Sicherer SH, Sampson HA. Food hypersensitivity and atopic dermatitis; pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol. 1999;104 (3, pt 2):S114-S122.
13. Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014;133:291-307.
14. Sidbury R, Tom WL, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 4. prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014;71:1218-1233.
15. Marenholz I, Rivera VA, Esparza-Gordillo J, et al. Association screening in the epidermal differentiation complex (EDC) identifies an SPRR3 repeat number variant as a risk factor for eczema. J Invest Dermatol. 2011;131:1644-1649.
16. Burks AW, Jones SM, Boyce JA, et al. NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric population. Pediatrics. 2011;128:955-965.
17. Ong PY. Association between egg and staphylococcal superantigen IgE sensitizations in atopic dermatitis. Allergy Asthma Proc. 2014;35:346-348.
18. Botteman M, Detzel P. Cost-effectiveness of partially hydrolyzed whey protein formula in the primary prevention of atopic dermatitis in high-risk urban infants in Southeast Asia. Ann Nutr Metab. 2015;66(suppl 1):26-32.
19. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database Syst Rev. 2012;9:CD000133.
20. Yum HY, Lee SY, Lee KE, et al. Genetically modified and wild soybeans: an immunologic comparison. Allergy Asthma Proc. 2005;26:210-216.
21. Mathur C, Kathuria PC, Dahiya P, et al. Lack of detectable allergenicity in genetically modified maize containing "Cry" proteins as compared to native maize based on in silico & in vitro analysis. PLoS One. 2015;10:e0117340.
22. Dubois AE, Pagliarani G, Brouwer RM, et al. First successful reduction of clinical allergenicity of food by genetic modification: Mal d 1-silenced apples cause fewer allergy symptoms than the wild-type cultivar [published online July 24, 2015]. Allergy. 2015;70:1406-1412.
23. Silverberg JI, Lee-Wong M, Silverberg NB. Complementary and alternative medicines and childhood eczema: a US population-based study. Dermatitis. 2014;25:246-254.
24. Pfab F, Schalock PC, Napadow V, et al. Complementary integrative approach for treating pruritus. Dermatol Ther. 2013;26:149-156.
25. Stickel F, Shouval D. Hepatotoxicity of herbal and dietary supplements: an update. Arch Toxicol. 2015;89:851-865.
26. Schachner L, Field T, Hernandez-Reif M, et al. Atopic dermatitis symptoms decreased in children following massage therapy. Pediatr Dermatol. 1998;15:390-395.
27. Pfab F, Schalock PC, Napadow V, et al. Acupuncture for allergic disease therapy-the current state of evidence. Expert Rev Clin Immunol. 2014;10:831-841.
28. Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132:1132-1138.
29. Silverberg JI, Norowitz KB, Kleiman E, et al. Association between varicella zoster virus infection and atopic dermatitis in early and late childhood: a case-control study. J Allergy Clin Immunol. 2010;126:300-305.
30. Welliver RC, Wong DT, Sun M, et al. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med. 1981;305:841-846.
31. Foolad N, Brezinski EA, Chase EP, et al. Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids. JAMA Dermatol. 2013;149:350-355.
32. Kalliomäki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357:1076-1079.
33. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119:184-191.
34. Bronsnick T, Murzaku EC, Rao BK. Diet in dermatology: part I: atopic dermatitis, acne, and nonmelanoma skin cancer. J Am Acad Dermatol. 2014;71:1039. e1-1039. e12.
35. Du Toit G, Roberts G, Sayre PH, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372:803-813.
36. Fleischer DM, Sicherer S, Greenhawt M, et al. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants [published online October 2015]. Allergy. 2015;70:1193-1195.
37. Kim J, Cho Y. Gromwell (Lithospermum erythrorhizon) supplementation enhances epidermal levels of cera-mides, glucosylceramides, glucocerebrosidase, and acidic sphingomyelinase in NC/Nga mice. J Med Food. 2013;16:927-933.
38. Choi JH, Jin SW, Han EH, et al. Platycodon grandiflorum root-derived saponins attenuate atopic dermatitis-like skin lesions via suppression of NF-B and STAT1 and activation of Nrf2/ARE-mediated heme oxygenase-1. Phytomedicine. 2014;21:1053-1061.
39. Kim T, Park K, Jung HS, et al. Evaluation of anti-atopic dermatitis activity of Hypsizigus marmoreus extract. Phytother Res. 2014;28:1539-1546.
40. Kim JR, Choi J, Kim J, et al. 20-O-D-glucopyranosyl-20(S)-protopanaxadiol-fortified ginseng extract attenuates the development of atopic dermatitis-like symptoms in NC/Nga mice. J Ethnopharmacol. 2014;151:365-371.
41. Weise C, Ernst D, van Tol EA, et al. Dietary polyunsaturated fatty acids and non-digestible oligosaccharides reduce dermatitis in mice. Pediatr Allergy Immunol. 2013;24:361-367.
42. Tanabe S, Hochi S. Oral administration of a galactooligosaccharide preparation inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice. Int J Mol Med. 2010;25:331-336.
43. Arslanoglu S, Moro GE, Boehm G, et al. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents. 2012;26 (3 suppl):49-59.
44. Shikino K, Ikusaka M, Yamashita T. Vitamin D-deficient osteomalacia due to excessive self-restrictions for atopic dermatitis [published online July 4, 2014] . BMJ Case Rep.
45. Kim J, Kwon J, Noh G, et al. The effects of elimination diet on nutritional status in subjects with atopic dermatitis. Nutr Res Pract. 2013;7:488-494.
46. Silverberg NB, Lee-Wong M. Generalized yellow discoloration of the skin. Cutis. 2014;93:E11-E12.
47. Hon KL, Nip SY, Cheung KL. A tragic case of atopic eczema: malnutrition and infections despite multivitamins and supplements. Iran J Allergy Asthma Immunol. 2012;11:267-270.
48. Diamanti A, Pedicelli S, D'Argenio P, et al. Iatrogenic kwashiorkor in three infants on a diet of rice beverages. Pediatr Allergy Immunol. 2011;22:878-879.
49. Pillai K, Acharya S. Iatrogenic kwashiorkar. Indian Pediatr. 2010;47:540-541.
50. Price A, Ramachandran S, Smith GP, et al. Oral allergy syndrome (pollen-food allergy syndrome). Dermatitis. 2015;26:78-88.
51. Mattila L, Kilpelaïnen M, Terho EO, et al. Food hypersensitivity among Finnish university students: association with atopic diseases. Clin Exp Allergy. 2003;33:600-606.
52. Paulsen E, Christensen LP, Andersen KE. Tomato contact dermatitis. Contact Dermatitis. 2012;67:321-327.
53. Di Leo E, Nettis E, Cardinale F, et al. Tomato atopy patch test in adult atopic dermatitis: diagnostic value and comparison among different methods. Allergy. 2009;64:659-663.